Sutro Biopharma (STRO) net margin is -1.5%
Sutro Biopharma (STRO) net margin is -1.5% as of 2024-12-31. That figure is from Lician’s product cache for this healthcare name — not a placeholder and not copied across tickers.
Read the full STRO research page for quote, filings, and the rest of the model. This satellite exists so “Sutro Biopharma net margin” can rank with the actual number, then send you to /stock/stro.